As with the intravenous form, subcutaneous anifrolumab shows clinically meaningful benefits and favorable safety when added ...
Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in ...
Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...
Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...
A new underground industry has emerged where people are buying raw compounds for Ozempic, Botox, filler and skin-tightening treatments directly from Chinese suppliers — and injecting them at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback